Spots Global Cancer Trial Database for endometrial cancer
Every month we try and update this database with for endometrial cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| MR-HIFU for Recurrent Gynaecological Cancer | NCT02714621 | Cervical Cancer Endometrial Can... Uterine Cancer Ovarian Cancer Vaginal Cancer Vulvar Cancer | Magnetic Resona... | 18 Years - | Institute of Cancer Research, United Kingdom | |
| Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer | NCT00003946 | Endometrial Can... | danazol | - | GOG Foundation | |
| AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED) | NCT00122343 | Endometrial Can... | ridaforolimus | 18 Years - | Merck Sharp & Dohme LLC | |
| Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors | NCT03722030 | Endometrial Can... | Baseline Measur... Strength-Traini... Mid-point Measu... Post-Study Meas... | 18 Years - 74 Years | University of Wisconsin, Madison | |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
| Vaginal Fluid Collection for Detection of Endometrial Cancer | NCT06294886 | Endometrial Can... | Screening test ... | 18 Years - | Innovis LLC | |
| A Survivorship Care Plan for Gynaecological Cancer Patients | NCT01582906 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | 18 Years - 60 Years | Royal Marsden NHS Foundation Trust | ||
| Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients | NCT05529303 | Cervix Cancer Uterine Cancer Ovarian Cancer Endometrial Can... Vulva Cancer Grief Femininity | Such as art the... | 18 Years - 65 Years | Afyonkarahisar Health Sciences University | |
| A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus | NCT02744898 | Endometrial Can... | Carboplatin AUC Abraxane | 18 Years - | NYU Langone Health | |
| 2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy | NCT02091050 | Cervix Cancer Endometrial Can... | 2D HDR planning 3D HDR planning | 18 Years - 85 Years | AC Camargo Cancer Center | |
| Hyperpolarized 13C MRI for Cancer Immunotherapy | NCT05805358 | Gynecologic Can... Cervical Cancer Endometrial Can... Ovarian Cancer | Hyperpolarized ... | 20 Years - | Chang Gung Memorial Hospital | |
| HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China | NCT06238284 | Cervical Cancer Endometrial Can... Ovarian Cancer HER2 Expression | no intervention | 18 Years - 75 Years | Chongqing University Cancer Hospital | |
| First in Human Study to Evaluate AZD8205 in Patients With Advanced or Metastatic Solid Malignancies | NCT05123482 | Breast Cancer Biliary Tract C... Ovarian Cancer Endometrial Can... | AZD8205 | 18 Years - | AstraZeneca | |
| Screening for Endometrial Abnormalities in Overweight and Obese Women | NCT01922778 | Endometrial Can... | Endometrial Bio... | 18 Years - 65 Years | St. Luke's-Roosevelt Hospital Center | |
| Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer | NCT03836157 | Endometrial Can... Endometrial Ade... Endometrial Ser... Endometrial Cle... | Mirvetuximab So... Bevacizumab | 18 Years - | University of Oklahoma | |
| Circulating Tumor DNA Study in Patients With Endometrial Cancer | NCT05955079 | Endometrial Can... | Whole blood | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT04781088 | Platinum-Resist... Platinum-Resist... Platinum-Resist... Recurrent Endom... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... | Lenvatinib Paclitaxel Pembrolizumab | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers | NCT01523678 | Ovarian Cancer Endometrial Can... Uterine Cervica... | Filgrastim Paclitaxel Carboplatin | 18 Years - | Belgian Gynaecological Oncology Group | |
| Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer | NCT02096783 | Anxiety Disorde... Cervical Cancer Endometrial Can... Female Reproduc... Gestational Tro... Ovarian Epithel... Ovarian Germ Ce... Sexual Dysfunct... Uterine Sarcoma Vaginal Cancer Vulvar Cancer | informational i... counseling inte... questionnaire a... | 18 Years - | University of Wisconsin, Madison | |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | NCT04660929 | HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm... | CT-0508 Pembrolizumab | 18 Years - | Carisma Therapeutics Inc | |
| The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study | NCT04122235 | Gynecologic Can... Gynecologic Neo... Ovarian Cancer Endometrial Can... Cervical Cancer Vulvar Cancer | LETSGO follow-u... | 18 Years - | Sorlandet Hospital HF | |
| Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer | NCT03016338 | Endometrial Can... | Niraparib TSR-042 | 18 Years - | University Health Network, Toronto | |
| Sentinel Node in Endometrial Cancer | NCT04492995 | Endometrial Can... | injection via T... injection via T... | 18 Years - | Fundacion Clinic per a la Recerca Biomédica | |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | NCT03452774 | Cancer, Metasta... Cancer Cancer of Pancr... Cancer of Liver Cancer of Stoma... Cancer Liver Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Cervi... Cancer of Colon Cancer of Laryn... Cancer, Lung Cancer, Breast Cancer, Advance... Cancer Prostate Cancer of Neck Cancer of Skin Neuroendocrine ... Carcinoma Mismatch Repair... BRCA Gene Rearr... Non Hodgkin Lym... Leukemia Non Small Cell ... Cholangiocarcin... Glioblastoma Central Nervous... Melanoma Urothelial Carc... Bladder Cancer Ovarian Cancer Endometrial Can... Testicular Canc... Breast Cancer COVID Myelofibrosis Myeloproliferat... Myeloproliferat... Follicular Lymp... Mantle Cell Lym... Marginal Zone L... Myelodysplastic... | Clinical Trial ... | - | Massive Bio, Inc. | |
| Iron Prehabilitation in Endometrial Cancer | NCT06049693 | Endometrial Can... Perioperative C... Prehabilitation | Ferrous Glucona... | 18 Years - 79 Years | National and Kapodistrian University of Athens | |
| Sentinel Node Mapping in High Risk Endometrial Cancer | NCT03366051 | Endometrial Can... Lymph Node Meta... | Sentinel Node M... Lymphadenectomy | 18 Years - 75 Years | AC Camargo Cancer Center | |
| Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer | NCT03900104 | Endometrial Can... Sentinel Lymph ... | Transcervical e... Cervical inject... | 18 Years - 90 Years | Kocaeli University | |
| SLNM in Endometrial Cancer Combined With OSNA | NCT02826291 | Endometrial Can... | RD-100i, OSNA | 18 Years - | Charles University, Czech Republic | |
| Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO) | NCT03580421 | Endometrial Can... Endometrial Can... | ambulatory surg... standard surger... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) | NCT03694262 | Endometrial Can... Uterine Carcino... | Rucaparib Bevacizumab Atezolizumab | 18 Years - | Medical College of Wisconsin | |
| the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer | NCT03908996 | Endometrial Can... Overweight | Profile by Sanf... | 18 Years - | Sanford Health | |
| Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia | NCT04362046 | Endometrial Hyp... Endometrial Can... Gynecologic Can... | Hysteroscopic u... | 19 Years - 39 Years | Vancouver Coastal Health Research Institute | |
| Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation | NCT05489848 | Endometrial Can... | Paclitaxel Carboplatin Cisplatin EBRT VBT | 18 Years - 85 Years | Fudan University | |
| Registry Platform Ovarian and Endometrial Cancer | NCT05129969 | Ovarian Cancer Endometrial Can... Ovary Neoplasm Endometrial Neo... Carcinoma, Ovar... Carcinoma Neoplasm, Ovari... | Physician's cho... | 18 Years - | iOMEDICO AG | |
| TAS-116 Plus Palbociclib in Breast and Rb-null Cancer | NCT05655598 | Advanced Breast... Treatment-Refra... Retinoblastoma ... SCLC Soft Tissue Sar... Endometrial Can... Bladder Cancer | Palbociclib Ora... TAS-116 TAS-116 TAS-116 | 18 Years - | Brown University | |
| TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers | NCT04485013 | Cancer | TTX-080 TTX-080 pembrolizumab cetuximab | 18 Years - | Tizona Therapeutics, Inc | |
| A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors | NCT04073680 | Breast Cancer Endometrial Can... Lung Cancer Colo-rectal Can... Head and Neck C... | Serabelisib Canagliflozin 3... | 18 Years - | Petra Pharma | |
| Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer | NCT03900104 | Endometrial Can... Sentinel Lymph ... | Transcervical e... Cervical inject... | 18 Years - 90 Years | Kocaeli University | |
| 2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial | NCT02320565 | Endometrial Can... | 3D Laparoscopy Standard Laparo... | - 75 Years | Catholic University of the Sacred Heart | |
| Endometrial Cancer Recurrence in Patients Taking Metformin | NCT05192850 | Recurrent Endom... | Metformin use | 18 Years - 99 Years | WellSpan Health | |
| Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer | NCT02665962 | Obese Endometrial Can... | Perioperative C... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma | NCT05273099 | Cancer of Endom... | 18 Years - | Università degli Studi di Ferrara | ||
| AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies | NCT01065662 | Endometrial Can... Ovarian Cancer Cervical Cancer Fallopian Tube ... Peritoneal Canc... | temsirolimus cediranib | 18 Years - | Dana-Farber Cancer Institute | |
| Hyperpolarized 13C MRI for Cancer Immunotherapy | NCT05805358 | Gynecologic Can... Cervical Cancer Endometrial Can... Ovarian Cancer | Hyperpolarized ... | 20 Years - | Chang Gung Memorial Hospital | |
| Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer | NCT00003135 | Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer | fluorouracil pegylated lipos... hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
| Optimising Cardiovascular Health in Endometrial Cancer Survivors | NCT05216913 | Endometrial Can... Cardiovascular ... | Lifestyle modif... Cardiovascular ... QRISK 3 Score | 18 Years - 110 Years | University of Manchester | |
| Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers | NCT02725489 | Breast Cancer Ovarian Cancer Fallopian Tube ... Primary Periton... Uterine Cancer Cervical Cancer Endometrial Can... | Vigil Durvalumab | 18 Years - | Mary Crowley Medical Research Center | |
| A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer | NCT05634499 | Endometrial Can... | Giredestrant | 18 Years - | Hoffmann-La Roche | |
| Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project | NCT01691144 | Endometrial Can... Ovarian Cancer Cervical Cancer | 19 Years - | University of Oslo | ||
| A Controlled Study of Quality of Life and it's Related Factors Among Gynecological Cancer Survivors | NCT01187706 | Cervical Cancer Ovarian Cancer Endometrial Can... | 20 Years - 70 Years | National Taiwan University Hospital | ||
| Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer | NCT05931445 | Breast Cancer Lung Cancer Colorectal Canc... Liver Cancer Stomach Cancer Endometrial Can... Ovarian Cancer Squamous Cell C... | e-PRO monitorin... | 18 Years - | Comprehensive Support Project for Oncology Research | |
| Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors | NCT02988817 | Ovarian Cancer Cervical Cancer Endometrial Can... Non Small Cell ... Thyroid Cancer Melanoma Sarcoma Solid Tumors | Enapotamab vedo... | 18 Years - | Genmab | |
| SC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial Cancers | NCT03138408 | Cancer | SC-004 ABBV-181 | 18 Years - | AbbVie | |
| Choices About Genetic Testing And Learning Your Risk With Smart Technology | NCT06184867 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... Breast Cancer Pancreas Cancer Colorectal Canc... Endometrial Can... Prostate Cancer | Relational Agen... Clinical Letter | 18 Years - | Rutgers, The State University of New Jersey | |
| Performance of Ultrasound in Women With Postmenopausal or Abnormal Uterine Bleeding Between White and Black Ethnic Groups- a Retrospective Cohort Study. | NCT06293066 | Postmenopausal ... Endometrial Can... | Ultrasound | 45 Years - | King's College Hospital NHS Trust | |
| Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome | NCT05257057 | Lynch Syndrome Endometrial Can... Endometrial Hyp... Mismatch Repair... Microsatellite ... | Immunohistochem... | 18 Years - 99 Years | WellSpan Health | |
| A Controlled Study of Quality of Life and it's Related Factors Among Gynecological Cancer Survivors | NCT01187706 | Cervical Cancer Ovarian Cancer Endometrial Can... | 20 Years - 70 Years | National Taiwan University Hospital | ||
| Risk Factors for Endometrial Cancer in Black Women | NCT00514254 | Endometrial Can... | questionnaire a... study of socioe... evaluation of c... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018 | NCT04590326 | Ovarian Cancer Fallopian Tube ... Primary Periton... Endometrial Can... | REGN5668 Cemiplimab REGN4018 Sarilumab | 18 Years - | Regeneron Pharmaceuticals | |
| REM (Risk Of Endometrial Malignancy) | NCT01830192 | Endometrial Dis... | Training set VERIFICATION SE... | 45 Years - 80 Years | Campus Bio-Medico University | |
| Adipocytokines in Endometrial Cancer | NCT04697264 | Endometrial Can... Obesity | Blood and tissu... | - | University of Surrey | |
| Sentinel Node in Endometrial Cancer | NCT04492995 | Endometrial Can... | injection via T... injection via T... | 18 Years - | Fundacion Clinic per a la Recerca Biomédica | |
| Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors | NCT02135562 | Endometrial Can... Obesity | Dietary Interve... Informational M... Dietary Educati... Weight Maintena... Average score o... | 18 Years - 70 Years | Case Comprehensive Cancer Center | |
| Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer | NCT00471120 | Uterine Cancer Endometrial Can... | P2x7 assay | 18 Years - | CytoCore, Inc. | |
| Effectiveness of Care in Certified Cancer Centres in Germany | NCT04334239 | Colorectal Canc... Breast Cancer Ovarian Cancer Cervix Cancer Endometrial Can... Bronchial Cance... Prostate Cancer Head and Neck T... CNS Tumor Pancreatic Canc... | Oncological cer... | 18 Years - | Technische Universität Dresden | |
| Chemotherapy in Treating Patients With Sarcoma of the Uterus | NCT00005643 | Endometrial Can... Sarcoma | pegylated lipos... | 21 Years - | GOG Foundation | |
| Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer | NCT05819892 | Endometrial Can... | Paclitaxel Carboplatin Dostarlimab Cisplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Survivorship Promotion In Reducing IGF-1 Trial | NCT02431676 | Breast Cancer Prostate Cancer Lung Cancer Colon Cancer Melanoma of Ski... Endometrial Can... Liver Cancer Pancreatic Canc... Rectal Cancer Kidney Cancer Other Solid Mal... | Metformin Coach Directed ... Self-control we... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Methods for Increasing Genetic Testing Uptake in Michigan | NCT05162846 | Breast Cancer Colorectal Canc... Ovarian Cancer Prostate Cancer Pancreatic Canc... Endometrial Can... History of Canc... | Publicly availa... Virtual genetic... Motivational in... | 18 Years - | University of Michigan Rogel Cancer Center | |
| A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma | NCT01797523 | Endometrial Can... | Metformin Letrozole Everolimus | 18 Years - | M.D. Anderson Cancer Center | |
| Registry Platform Ovarian and Endometrial Cancer | NCT05129969 | Ovarian Cancer Endometrial Can... Ovary Neoplasm Endometrial Neo... Carcinoma, Ovar... Carcinoma Neoplasm, Ovari... | Physician's cho... | 18 Years - | iOMEDICO AG | |
| Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer | NCT06253494 | Endometrial Can... Cancer of Endom... Carcinoma of En... Endometrial Car... | AdHER2DC vaccin... Pembrolizumab N-803 Lenvatinib PATHWAY HER2 (4... | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes | NCT06115577 | Endometrial Hyp... Endometrial Hyp... Endometrial Can... Peripheral Bloo... Postmenopause Estrogen Recept... Progesterone Re... | endometrial tis... | 53 Years - 80 Years | Pirogov Russian National Research Medical University | |
| Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer | NCT00258362 | Endometrial Can... | carboplatin docetaxel radiation thera... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery | NCT00448643 | Endometrial Can... | Vaginal Brachyt... Cisplatin Whole Abdominal... | 18 Years - 80 Years | University of Miami | |
| Development and Management of Registry in Patients With Gynecologic Cancer in Korea | NCT05912972 | Cervical Cancer Endometrial Can... Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Patient registr... | 18 Years - | Asan Medical Center | |
| Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers | NCT03212404 | Lung Neoplasms Carcinoma, Non-... Carcinoma, Smal... Malignant Mesot... Head and Neck C... Melanoma Merkel Cell Car... Renal Cell Carc... Urothelial Carc... Classical Hodgk... Cutaneous Squam... Non Hodgkin Lym... Endometrial Can... | CK-301 (cosibel... | 18 Years - | Checkpoint Therapeutics, Inc. | |
| S9630, Medroxyprogesterone in Treating Women With Breast Cancer | NCT00002920 | Breast Cancer Endometrial Can... | medroxyprogeste... tamoxifen citra... adjuvant therap... | 18 Years - | SWOG Cancer Research Network | |
| TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer | NCT03955978 | Endometrial Can... Cancer of the E... | TSR-042 Brachytherapy Endometrial bio... Blood draw for ... | 18 Years - | Washington University School of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
